杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/22 | 2,449 | 2,469 | 2,431 | 2,445 | +6 | +0.2% | 207,500 |
2018/05/21 | 2,450 | 2,464 | 2,425 | 2,439 | -6 | -0.2% | 209,300 |
2018/05/18 | 2,448 | 2,468 | 2,426 | 2,445 | +19 | +0.8% | 285,400 |
2018/05/17 | 2,416 | 2,448 | 2,413 | 2,426 | +21 | +0.9% | 352,700 |
2018/05/16 | 2,335 | 2,414 | 2,335 | 2,405 | +83 | +3.6% | 573,400 |
2018/05/15 | 2,260 | 2,334 | 2,260 | 2,322 | +72 | +3.2% | 340,800 |
2018/05/14 | 2,210 | 2,256 | 2,209 | 2,250 | +41 | +1.9% | 231,500 |
2018/05/11 | 2,155 | 2,216 | 2,155 | 2,209 | +38 | +1.8% | 360,300 |
2018/05/10 | 2,146 | 2,200 | 2,103 | 2,171 | +24 | +1.1% | 310,900 |
2018/05/09 | 2,152 | 2,186 | 2,130 | 2,147 | -9 | -0.4% | 309,200 |
2018/05/08 | 2,136 | 2,174 | 2,136 | 2,156 | +10 | +0.5% | 113,800 |
2018/05/07 | 2,156 | 2,159 | 2,127 | 2,146 | -6 | -0.3% | 96,300 |
2018/05/02 | 2,154 | 2,156 | 2,129 | 2,152 | -13 | -0.6% | 52,300 |
2018/05/01 | 2,144 | 2,176 | 2,141 | 2,165 | +21 | +1% | 152,000 |
2018/04/27 | 2,152 | 2,161 | 2,134 | 2,144 | +4 | +0.2% | 89,500 |
2018/04/26 | 2,139 | 2,147 | 2,128 | 2,140 | +6 | +0.3% | 122,200 |
2018/04/25 | 2,115 | 2,140 | 2,108 | 2,134 | +23 | +1.1% | 110,200 |
2018/04/24 | 2,089 | 2,112 | 2,077 | 2,111 | +41 | +2% | 104,300 |
2018/04/23 | 2,087 | 2,095 | 2,066 | 2,070 | -14 | -0.7% | 68,000 |
2018/04/20 | 2,109 | 2,109 | 2,076 | 2,084 | -26 | -1.2% | 131,100 |
2018/04/19 | 2,130 | 2,134 | 2,107 | 2,110 | -13 | -0.6% | 171,300 |
2018/04/18 | 2,125 | 2,133 | 2,117 | 2,123 | +1 | ±0% | 93,200 |
2018/04/17 | 2,124 | 2,143 | 2,115 | 2,122 | -2 | -0.1% | 158,300 |
2018/04/16 | 2,080 | 2,132 | 2,066 | 2,124 | +55 | +2.7% | 132,000 |
2018/04/13 | 2,100 | 2,100 | 2,064 | 2,069 | -33 | -1.6% | 148,000 |
2018/04/12 | 2,090 | 2,118 | 2,090 | 2,102 | +15 | +0.7% | 169,100 |
2018/04/11 | 2,112 | 2,112 | 2,080 | 2,087 | -24 | -1.1% | 131,700 |
2018/04/10 | 2,116 | 2,129 | 2,095 | 2,111 | -10 | -0.5% | 148,500 |
2018/04/09 | 2,126 | 2,133 | 2,108 | 2,121 | -7 | -0.3% | 126,800 |
2018/04/06 | 2,112 | 2,145 | 2,102 | 2,128 | +16 | +0.8% | 235,600 |
2018/04/05 | 2,074 | 2,134 | 2,073 | 2,112 | +61 | +3% | 268,600 |
2018/04/04 | 2,016 | 2,055 | 2,007 | 2,051 | +42 | +2.1% | 162,900 |
2018/04/03 | 1,981 | 2,015 | 1,969 | 2,009 | +22 | +1.1% | 189,000 |
2018/04/02 | 2,000 | 2,002 | 1,985 | 1,987 | -12 | -0.6% | 127,400 |
2018/03/30 | 2,013 | 2,013 | 1,981 | 1,999 | ±0 | ±0% | 116,800 |
2018/03/29 | 2,032 | 2,032 | 1,978 | 1,999 | -15 | -0.7% | 233,600 |
2018/03/28 | 1,986 | 2,015 | 1,977 | 2,014 | -13 | -0.6% | 135,100 |
2018/03/27 | 1,994 | 2,028 | 1,979 | 2,027 | +34 | +1.7% | 184,100 |
2018/03/26 | 1,992 | 2,003 | 1,973 | 1,993 | -10 | -0.5% | 151,400 |
2018/03/23 | 2,017 | 2,038 | 2,001 | 2,003 | -64 | -3.1% | 175,900 |
2018/03/22 | 2,050 | 2,068 | 2,027 | 2,067 | +18 | +0.9% | 190,000 |
2018/03/20 | 2,043 | 2,084 | 2,043 | 2,049 | +4 | +0.2% | 213,900 |
2018/03/19 | 2,048 | 2,049 | 2,018 | 2,045 | -12 | -0.6% | 133,900 |
2018/03/16 | 2,085 | 2,085 | 2,054 | 2,057 | -33 | -1.6% | 189,500 |
2018/03/15 | 2,086 | 2,098 | 2,078 | 2,090 | +4 | +0.2% | 152,800 |
2018/03/14 | 2,066 | 2,091 | 2,050 | 2,086 | +11 | +0.5% | 247,000 |
2018/03/13 | 2,025 | 2,079 | 2,024 | 2,075 | +56 | +2.8% | 225,200 |
2018/03/12 | 2,022 | 2,023 | 2,004 | 2,019 | +12 | +0.6% | 150,900 |
2018/03/09 | 2,019 | 2,032 | 1,997 | 2,007 | +12 | +0.6% | 225,000 |
2018/03/08 | 2,000 | 2,014 | 1,984 | 1,995 | +3 | +0.2% | 193,500 |
1701~
1750
件表示中 / 3696件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 145,800円 | +8.8% | +99.9% | 3.57% | 9.31倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,200円 | +3.1% | -6.5% | 2.21% | 10.08倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 219,500円 | +0.4% | -8.4% | 2.41% | 28.18倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,200円 | +20.3% | - | 0.00% | 150.26倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム